AVS Bio, headquartered in Norwich, Connecticut, acquired Biorbyt Ltd., a global supplier of bio-reagents, antibodies, proteins, and other biomaterials for life science research, expanding its catalog and ecommerce capabilities to serve pharma, biotech, and academia markets worldwide.
AVS Bio is a leading global provider of critical inputs and services for the bioprocessing and biologics industries, supplying manufacturers with specific pathogen free eggs, cell products, antibodies, and organoid growth factors while offering antibody discovery and diagnostic testing services. Founded in 2011 and headquartered in Cambridge, UK, Biorbyt maintains a catalog of more than 1 million SKUs and will continue operating under its existing leadership as part of the AVS Bio platform.
Jac Price, CEO of AVS Bio, said, "With the treatment and prevention of disease becoming ever more advanced, personalized, and urgent, sophisticated biomaterials capabilities play a crucial role in their delivery. Biorbyt, with its expansive portfolio of antibodies, proteins, and reagents, and advanced ecommerce platform, marks an important step in our journey to becoming a truly diversified, leading and global biomaterials provider and will allow us to reach more customers in more geographies than ever before."
AVS Bio is a portfolio company of Arlington Capital Partners, a private investment firm specializing in government-regulated industries.
"Since our initial investment, our vision alongside AVS Bio's leadership team has been to build it into a scaled life sciences platform with the breadth and capabilities to support customers across the research and development lifecycle," said Malcolm Little, Partner at Arlington Capital Partners. "Biorbyt is highly complementary to AVS Bio's capabilities and will materially broaden its product offering while adding digital commerce capabilities and the deep scientific and commercial expertise of Biorbyt's exceptional leadership team."
Dr. Tillmann Ziegert and Qun Yang, Co-Founders of Biorbyt, said, "We are very excited to join the growing AVS Bio family. Our combined catalog, along with our ecommerce platform and data-driven commercial tools, creates a powerful engine to serve researchers around the world and bring an even broader portfolio of high-quality biomaterials to our joint global customer base."
